PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Cellaed Life Saver PTY Ltd

USPTO PatentsView assignee record - 7 granted patents across 1 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Cellaed ranks #34,697 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 1 technology areas.

#34,697
of 49,997 US assignees by volume
19th percentile
by Innovation Score (26.0/100)
3.3
avg claims per patent

USPTO PatentsView assignee plate

Corpus R34697 · Foreign Corporation #34,697 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 7 grants
  • MID-PACK #34,697/49,997
  • PHOTO-FINISH Cazena
  • CPC-NARROW A61N · 1 areas
  • INNOV-THIN 26.0/100
  • CLAIMS-SPARSE 3.3 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2020–2025 · 6y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Cazena, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cellaed’s 26.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Cellaed

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Cellaed's Innovation Score is 26.0/100 (19th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Cellaed?

Each dot is one of Cellaed’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cellaed’s own 3.3 claims/patent is at or below the 15.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Cellaed vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 6.97.07.077.07.07.1 0510152025 Granted patents (volume) Avg claims / patent Cazena, Inc. - 7, 16CazenaCegnum LLC - 7, 13.29CegnumCell and Molecular Tissue Engineering, LLC - 7, 21.29Cell and Molecula…CellaVision AB - 7, 15.43Cellavision ABCellink AB - 7, 12Cellink ABCellink Bioprinting AB - 7, 15.57Cellink Bioprinti…Cellotape, Inc. - 7, 17.43CellotapeCellply S.R.L - 7, 11.71Cellply S R LCellaed Life Saver PTY Ltd - 7, 3.29Cellaed Life Save…
Cellaed vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cellaed's grants concentrate

Cellaed Life Saver PTY Ltd is a focused PatentsView assignee: 1 CPC subclasses with 14.3% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2022 (3 grants) versus a trough of 1 in 2020. By volume, Cellaed sits between Cazena, Inc. and Cellply S.R.L.

Cellaed's three-year grant acceleration

Cellaed Life Saver PTY Ltd shows 4 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Cellaed's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Cellaed holds 7 patents at rank #34,803, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Cellaed

By rank, the assignees closest to #34,803 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Cellaed's primary technology class.

Cellaed's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

26 19th percentile higher than 19% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 20202021202220232025 1
USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table
Cellaed Life Saver PTY Ltd patent grants by year, 2015–2025
Year Patents Granted Share of Period
2020 1 14.3%
2021 1 14.3%
2022 3 42.9%
2023 1 14.3%
2025partial year 1 14.3%

Which technologies does Cellaed Life Saver PTY Ltd patent most?

Top 1 of 1 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Cellaed Life Saver PTY Ltd's patent record in context - here's where to go next.

  • Cellaed Life Saver PTY Ltd's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 14.3% of its portfolio - see every assignee active in that class. Explore A61N
  • Ranked #34,697 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Cellaed Life Saver PTY Ltd against Cazena, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 26.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.